Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19). [PDF]
Narayanan G +11 more
europepmc +1 more source
Arterial Stiffness, Clinical-Functional Outcomes, and Quality of Life in Post-COVID-19 Patients: A Cross-Sectional Study. [PDF]
Luna BC +4 more
europepmc +1 more source
Danon Disease: Understanding the Role of LAMP2 Variants in Cardiomyopathy and Multisystemic Involvement. [PDF]
Ribeiro GNP +7 more
europepmc +1 more source
Position Statement on Multimodal Cardiac Imaging in Patients with Systemic Diseases - 2026. [PDF]
Hotta VT +27 more
europepmc +1 more source
Allopurinol in chronic kidney disease: navigating between pathophysiology, experimental evidence, and real-world challenges. [PDF]
Vargas-Santos AB +2 more
europepmc +1 more source
Analysis of Cardiopulmonary Exercise Test in Pre- and Post-COVID-19. [PDF]
Teixeira JAC.
europepmc +1 more source
Battle of the giants: KDIGO vs. Cochrane - who is the winner in the fight for blood pressure targets in chronic kidney disease? [PDF]
Rodrigues CIS, Moura AF, Bezerra R.
europepmc +1 more source
Troponin/Lymphocyte Ratio: Anticipating Immunotherapy-Induced Myocarditis. [PDF]
Miranda I, Augusto JB.
europepmc +1 more source
Key comorbidities in the development of post-COVID conditions: diabetes mellitus, hypertension, and obesity. [PDF]
Prediger KM +2 more
europepmc +1 more source
Recurrent Pericarditis: A Manifestation of Systemic Inflammation? [PDF]
Carvalho MRM.
europepmc +1 more source

